Xiling Jiang
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Antiplatelet Therapy and Cardiovascular Diseases
Papers in
- Oncology 5
- CAR-T cell therapy research 3
- Co-authors
- Stephan Schmidt (2 shared papers)Lawrence J. Lesko (2 shared papers)Weirong Wang (5 shared papers)Marc R. Theoret (5 shared papers)Richard Pazdur (4 shared papers)Lola A. Fashoyin‐Aje (2 shared papers)Steven J. Lemery (2 shared papers)Jiang Liu (2 shared papers)
- Journals
- Clinical Cancer Research (4 papers)European Journal of Pharmaceutical Sciences (2 papers)Clinical Pharmacokinetics (1 paper)The Oncologist (1 paper)Global Ecology and Conservation (1 paper)
- Partner nations
- United StatesChinaNetherlands
In The Last Decade
Xiling Jiang
17 papers receiving 471 citations
Peers
Comparison fields: 5 of 67
- Hepatology 67
- Cardiology and Cardiovascular Medicine 111
- Immunology 91
- Oncology 111
- Pharmacology 35
Countries citing papers authored by Xiling Jiang
This map shows the geographic impact of Xiling Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiling Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiling Jiang more than expected).
Fields of papers citing papers by Xiling Jiang
This network shows the impact of papers produced by Xiling Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiling Jiang. The network helps show where Xiling Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiling Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 151 | |
| 2 | 2020 | 139 | |
| 3 | 2018 | 41 | |
| 4 | 2016 | 31 | |
| 5 | 2015 | 25 | |
| 6 | 2020 | 20 | |
| 7 | 2018 | 19 | |
| 8 | 2023 | 17 | |
| 9 | 2023 | 14 | |
| 10 | 2022 | 10 | |
| 11 | 2020 | 9 | |
| 12 | 2024 | 4 | |
| 13 | 2015 | 4 | |
| 14 | 2024 | 2 | |
| 15 | 2024 | 1 | |
| 16 | 2016 | 1 | |
| 17 | [Comparison of apical root resorption of maxillary incisors between adolescents and adults after orthodontic treatment]. | 2021 | 1 |
| 18 | 2025 | 0 |
About Xiling Jiang
Xiling Jiang is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Genetics and Immunology, having authored 18 papers that have together received 489 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), CAR-T cell therapy research (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Acute Myeloid Leukemia Research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Renal cell carcinoma treatment (1 paper) and Inflammatory mediators and NSAID effects (1 paper). The work is most often cited by research in Hepatology (67 citations), Cardiology and Cardiovascular Medicine (111 citations), Immunology (91 citations), Oncology (111 citations) and Pharmacology (35 citations). Xiling Jiang has collaborated with scholars based in United States, China and Netherlands. Frequent co-authors include Stephan Schmidt, Lawrence J. Lesko, Weirong Wang, Marc R. Theoret, Richard Pazdur, Lola A. Fashoyin‐Aje, Steven J. Lemery, Jiang Liu, Kirsten B. Goldberg and William J. Jusko. Their work appears in journals such as Clinical Cancer Research, European Journal of Pharmaceutical Sciences, Clinical Pharmacokinetics, The Oncologist and Global Ecology and Conservation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.